Dr Nick Gottardo
Nick Gottardo is a clinician/scientist based in Perth, Western Australia. He is a paediatric oncologist/neuro-oncologist and Head of the Department of Paediatric Oncology and Haematology at Perth Children’s Hospital. He is also the Co-leader of the Brain Tumour Research Programme at the Telethon Kids Institute. He undertook his neuro-oncology fellowship at St Jude Children’s Research Hospital, where he developed extensive experience in mouse model generation and preclinical testing. The Brain Tumour Research Programme focuses on testing novel therapies using mouse model systems that more closely recapitulate the human disease, in order to test the effectiveness of new treatments for childhood brain tumours, so that the most promising therapies can be taken through to the clinic. Nationally, he is the Deputy Chair of the Australian and New Zealand Children’s Haematology/Oncology Group and Chair of the CNS Tumour Sub-group of the ANZCHOG. He the Study Chair of the AIM-BRAIN PROject (Access to Innovative Molecular diagnostic PROfiling) for paediatric brain tumours. This trial will develop a personalised molecular classification protocol, using state-of-the-art technologies, to molecularly fingerprint brain tumours for all children in Australasia. Internationally, he is the Study Chair of the Children’s Oncology Group’s front-line clinical trial for WNT subgroup medulloblastoma patients, which investigates therapy reduction for this subgroup of patients who have excellent survival on current therapy. He is also a member of the International Medulloblastoma Working Group.